N-(cyclopropylmethyl)-9-methyl-6-[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-9H-purine-8-carboxamide 、 9-cyclopropyl-6-[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-9H-purine-8-carboxylic acid 、
环丙胺 、
O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 、
N,N-二异丙基乙胺 在
9-cyclopropyl-N-(cyclopropylmethyl)-6-[4-(2-oxo-2.3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-9H-purine-8-carboxamide 、
乙酸铵 、
乙腈 作用下,
以
N,N-二甲基乙酰胺 为溶剂,
反应 18.0h,
以yielded 0.057 g of 9-cyclopropyl-N-(cyclopropylmethyl)-6-[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-9H-purine-8-carboxamide as a white solid的产率得到9-cyclopropyl-N-(cyclopropylmethyl)-6-[4-(2-oxo-2.3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-9H-purine-8-carboxamide